New drug targets in metastatic melanoma

E-ISSN： 1555-2039|232|2|134-141

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.232, Iss.2, 2014-01, pp. : 134-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment for metastatic melanoma: a new and evolving era

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 3, 2015-03 ,pp. : 273-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic Endobronchial Melanoma

Respiration, Vol. 77, Iss. 2, 2007-01 ,pp. : 214-214

Karger

Access to resources Recommend Favorite

Systemic therapy of metastatic melanoma

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 12, 2015-12 ,pp. : 1223-1237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combining BRAFV600E inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 9, 2015-09 ,pp. : 709-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

New-Onset Mediastinal and Central Nervous System Sarcoidosis in a Patient with Metastatic Melanoma Undergoing CTLA4 Monoclonal Antibody Treatment

Oncology Research and Treatment, Vol. 37, Iss. 6, 2014-05 ,pp. : 351-353

Karger

Access to resources Recommend Favorite